Brian Neill Resigns from Biosign Technologies Board

Brian Neill has resigned from the board of Biosign Technologies Inc., effective January 6, 2016.
According to the press release:

[Neill] states: “It is with reluctance that I am now leaving the board of Biosign, as so much work has been done turning the company around into a software-as-service company with a revenue stream from its operations in Germany. However I am also involved in a software company in the health care industry so to prevent any perceived or potential conflicts of interest, I thought it prudent to resign at this time.”
Dr. Michael Gross, chief executive officer of Biosign, has thanked Mr. Neill for his time on the board, noting that he received no remuneration during his tenure, and states, “We will now actively recruit for other suitably equipped directors to help us grow this company in our chosen specialty field, providing software that enables better care to be provided for people in their own homes.”
Biosign notes that at present the software Aiomed is operating in Germany in care facilities run by Caritas, Germany’s largest health care operator.

Click here to read the full press release.